Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

JTP-103237

Inquiry
Cat. No.: OB0425LY-110
Synonyms: JTP 103237; 1883864-16-1; 7-(4,6-Di-tert-butylpyrimidin-2-yl)-3-(4-(trifluoromethoxy)phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine; 7-(4,6-Ditert-butylpyrimidin-2-yl)-3-[4-(trifluoromethoxy)phenyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine
Size: 50 mg; 100 mg; 250 mg
CAS No.: 1883864-16-1
Compound CID: 91884614
JTP-103237

Specification

Description: JTP-103237 is a high-quality MGAT2 inhibitor that inhibits hMGAT2 and hMGAT3.
Formula Weight: 474.52
Applications: JTP-103237 can be used to regulate fat absorption, control blood glucose levels and prevent diet-induced obesity.
Storage: Storage at -20°C.
Formula: C24H29F3N6O
Appearance: Solid
Purity: ≥95%
Pathway: Metabolic enzyme/Protease
Target: Acyltransferase

Library Information

Inquiry

Copyright © Protheragen. All rights reserves.